Red X iconGreen tick iconYellow tick icon

Contact Details

Phone
+64 3 474 0999 extn 58538
Email
rob.walker@otago.ac.nz
Position
Professor, Mary Glendining Chair in Medicine
Department
Department of Medicine (Dunedin)
Qualifications
MB ChB MD(Otago) FRACP FASN FAHA
Research summary
Kidney health and disease
Memberships
  • Member International Society of Nephrology Nexus and Forefronts programme committee.
  • KDIGO lipid guidelines committee, CARI guidelines committee - Cardiovascular risk factors in renal disease.
  • Member CARI guidelines committee - Dialysis adequacy.
  • Honorary Secretary and Member Executive Council ASPN, with a strong interest in developing the links between Australia and New Zealand with South East Asia and the Pacific.
Clinical
  • Nephrology
  • Cardiovascular outcomes in kidney disease
  • Dialysis outcomes in the elderly
  • Acute kidney injury
  • Diabetic kidney disease

Research

Clinical research including cardiovascular risk factors associated with CKD; hypertension, obesity and inflammation; drug induced nephrotoxicity; drugs, exercise and kidney function; acute kidney injury; dialysis outcomes in the elderly.

Basic science research focused upon mechanisms of chronic interstitial fibrosis in a chronic-lithium animal model.

Funders include Health Research Council NZ, Lotteries Health, Kidney Health NZ, Otago Medical Research Foundation.

Over 180 publications.

Additional details

Director University of Otago Research Theme: The Kidney in Health and Disease.

Publications

Florance, J. A., Schollum, J. B. W., Pomeranc, A., Endre, Z. H., & Walker, R. J. (2024). Autosomal dominant hypercalciuric hypocalcaemia: The calcium-sensing receptor in renal calcium homeostasis and the impact of renal transplantation. Internal Medicine Journal. Advance online publication. doi: 10.1111/imj.16403 Journal - Research Other

Cashmore, B., Tunnicliffe, D. J., Palmer, S., Blythen, L., Boag, J., Kostner, K., … Patu, M., … Walker, R., on behalf of the CARI Guidelines Steering Committee. (2024). Australian and New Zealand Living Guideline cholesterol-lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence-practice gap. Nephrology. Advance online publication. doi: 10.1111/nep.14295 Journal - Research Article

Wilson, L. C., Ward, J., Wright, D. F. B., Green, S. C., Stocker, S. L., Putt, T. L., Schollum, J. B. W., & Walker, R. J. (2024). The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout. Nephrology. Advance online publication. doi: 10.1111/nep.14306 Journal - Research Other

Francis, A., Wainstein, M., Irish, G., Hafidz, M. I. A., Chen, T., Cho, Y., … and the Regional Board and ISN-GKHA Team Authors, including Walker, R. (2024). Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: Report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney International Supplements, 13, 110-122. doi: 10.1016/j.kisu.2024.01.004 Journal - Research Article

Wang, D.-X., Bao, S.-Y., Song, N.-N., Chen, W.-Z., Ding, X.-Q., Walker, R. J., & Fang, Y. (2024). FTO-mediated m6A mRNA demethylation aggravates renal fibrosis by targeting RUNX1 and further enhancing PI3K/AKT pathway. FASEB Journal, 38, e23436. doi: 10.1096/fj.202302041R Journal - Research Article

Back to top